Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1/CSF1R signaling abnormalities in the cell line GDM1. (Q39923623)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1/CSF1R signaling abnormalities in the cell line GDM1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

0 references

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

A Chase

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

B Schultheis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

S Kreil

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

J Baxter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

C Hidalgo-Curtis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

A Jones

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

L Zhang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

F H Grand

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

J V Melo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

30 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

358-364

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18971950%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2008.295

25 December 2019

exact match

0 references

cites work

Tyrosine 569 in the c-Fms juxtamembrane domain is essential for kinase activity and macrophage colony-stimulating factor-dependent internalization

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

ARG tyrosine kinase activity is inhibited by STI571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Critical role of STAT5 activation in transformation mediated by ZNF198-FGFR1.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Expression of v-fms and c-fms in the hemopoietic cell line FDC-P1.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Retroviral vectors for production of interleukin-12 in the bone marrow to induce a graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Production of high-titer helper-free retroviruses by transient transfection

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Amplification of a novel c-Kit activating mutation Asn(822)-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Activation of HLXB9 by juxtaposition with MYB via formation of t(6;7)(q23;q36) in an AML-M4 cell line (GDM-1).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Identification of somatic JAK1 mutations in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Mutational analysis of class III receptor tyrosine kinases (C-KIT, C-FMS, FLT3) in idiopathic myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

c-FMS mutational analysis in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Establishment and characterization of a new permanent cell line (GDM-1) from a patient with myelomonoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

The 2.7 A crystal structure of the autoinhibited human c-Fms kinase domain

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Structural and biochemical evidence for an autoinhibitory role for tyrosine 984 in the juxtamembrane region of the insulin receptor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Definition of an inhibitory juxtamembrane WW-like domain in the platelet-derived growth factor beta receptor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Switching on kinases: oncogenic activation of BRAF and the PDGFR family

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021

Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.295

7 January 2021